The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

In Brief

Martine Extermann receives top award from International Society of Geriatric Oncology

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

MARTINE EXTERMANN received the 2014 Paul Calabresi Award from the International Society of Geriatric Oncology. Extermann is the senior member of the Senior Adult Oncology and Health Outcomes & Behavior Programs at Moffitt Cancer Center.

Named after the first president of the society, the award recognizes individuals who have significantly contributed to the advancement of geriatric oncology. It is the highest award granted by the society.

Extermann received the award during the society’s annual meeting in Lisbon, Portugal. She gave a lecture on translational and clinical opportunities in geriatric oncology, focused on Moffitt’s Total Cancer Care Protocol and how it can be utilized for older cancer patients. The protocol provides a standard system for tracking patient molecular, clinical and epidemiological data and follows the patient throughout his or her lifetime.

Table of Contents

YOU MAY BE INTERESTED IN

Clinical

Oncofertility coverage mandates expand to 21 states and DC as political momentum builds
Gaps persist as patients face harrowing decisions and huge copays

The nagging pain in Mia Sandino’s right knee set in in September 2018, and throughout her freshman year at the University of Washington, she tried to ignore it. “I was being a very naive and invincible-feeling 19-year-old,” Sandino told The Cancer Letter. “I didn’t put two and two together that this area of the knee that...

By Claire Marie Porter and Sara Willa Ernst
Guest Editorial

My introduction to, and lessons learned from, Rick Pazdur

Rick Pazdur, MD, the newly appointed director for the Center for Drug Evaluation and Research at the FDA, has been described as “greyhound thin” as a result of his dedication to cycling and lifting weights in the gym each day and, for a long time, a vegetarian diet. I first met him when he was the director of the Office of Oncology Drug Products (ODP) within CDER, in 2009.
By Mikkael A. Sekeres
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account